CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Efficacy of topical 0.05% cyclosporine treatment in children with severe vernal keratoconjunctivitis
Authors
Altan-Yaycıoğlu R.
Cantürk-Uğurbaş S.
+5 more
Metindoğan S.
Pelit A.
Sızmaz S.
Çoban-Karataş M.
Özkale Y.
Publication date
1 January 2014
Publisher
'The Turkish Journal of Pediatrics'
Abstract
PubMedID: 25818961We aimed to determine the efficacy of topical cyclosporine in children with vernal keratoconjunctivitis refractory to topical mast cell stabilizer and antihistamine therapy. Thirty-one patients, 24 boys and 7 girls younger than 16 years of age, were included in the study. All patients were scored on a four-point scale from 0 to 3 for symptoms and signs. Each patient received topical cyclosporine 0.05% emulsion (Restasis, Allergan Inc., Irvine, CA, USA) four times daily in addition to preservative-free artificial tears and was followed for 6 months. The data was recorded before the initiation of treatment (day 0) and at the 1st, 3rd, and 6th months following treatment. After six months of treatment, severity of all symptoms and signs showed a statistically significant decrease (p<0.05). Patients did not report any serious adverse effects. Topical cyclosporine 0.05% emulsion treatment is a safe and effective treatment option for controlling the symptoms and signs of vernal keratoconjunctivitis in children. © 2014, Turkish Journal of Pediatrics. All rights reserved
Similar works
Full text
Available Versions
Çukurova University Institutional Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:openaccess.cu.edu.tr:20.50...
Last time updated on 06/02/2020